期刊文献+

替米沙坦对表达在卵母细胞上Kv1.5通道的抑制效应 被引量:1

Telmisartan inhibits the expression of cloned human Kv1.5 potassium channel in Xenopus oocytes
原文传递
导出
摘要 目的:研究替米沙坦对表达在卵母细胞上的克隆人类Kv1.5通道的作用,探讨其在心脏复极中的潜在效应。方法:在非洲爪蟾卵母细胞上异源表达克隆人类Kv1.5通道基因,使用双电极电压钳技术记录全细胞电流,检测药物对Ikur电流的影响。结果:替米沙坦以电压依赖性和浓度依赖性方式抑制Kv1.5通道电流,且对峰电流及1.5s末端电流的抑制效应不同,在1μmol/L浓度下,抑制效应分别达到(7.75±2.39)和(52.64±3.77),其半抑制浓度(IC50)分别为(2.25±0.97)μmol/L和(0.82±0.39)μmol/L。替米沙坦对通道的稳态失活没有显著改变,在对照条件下,V1/2的值为(14.47±3.71)mV,斜坡因子k为(23.24±3.86)mV;在1μmol/L替米沙坦作用下,V1/2和k的值分别为(14.38±4.62)mV和(26.26±5.04)mV(n=6,P>0.05)。同时,替米沙坦显著加速了Kv1.5通道的失活。在对照条件下,Kv1.5通道的失活慢时间常数是(693.74±23.16)ms,在应用1μmol/L替米沙坦后,其失活的慢时间常数下降为(523.85±10.28)ms(n=5,P<0.05)。结论:替米沙坦在临床有效浓度范围内能显著抑制表达在卵母细胞上的Ikur电流,提示它兼有选择性阻滞Kv1.5通道的作用。 Objective:To uncover the potential effects of telmisartan (an AT1 receptor blocker) in cardiac repolarization, by investigating the pharmacological effect of telmisartan on cloned human Kvl. 5 potassium channel expressed in Xenopus ooeytes. Method:Kvl. 5 cRNA channel gene was expressed in xenopus oocytes and channel current was recorded using standard two-microeleetrode voltage clamp techniques in control condition or telmisartan intervention. Result: Telmisartan inhibited Kv1. 5 channel in a concentration-and voltage-dependent manner, and the efficacy of blockade was different at peak and 1.5s end pulse currents, which was (21.48±2.40)% and( 95.67±9.09) % at the absence and presence of 1umol telmisartan, respectively. The IC50 is (2.25±1.14)umol and (0.82zk0.43)bLmol, respectively. The steady-state inactivation of Kv1. 5 is not significant altered, the V1/2 and slope factor were (14.47±3.71)mV (control) vs (14.38±4.62) mV and (23.24±3.86) mV (control) vs (26.26 ± 5.04) mV(n =6, P〉0.05) at the absence and presence of telmisartan, respectively. Meanwhile, telmisarran remarkably accelerated inactivation of the channel. In control condition, the slow time constant of inactiva tion was (693.74±23.16) ms, however, at 1 uM telmisartan, the slow time constant was (523.85±10.28) ms (n= 5, P〈0.05). Conclusion..Telmisartan significantly inhibits Ikur currents expressed in Xenopus occytes at clinical therapeutic concentration, which indicates its' combining selective Kvl. 5 channel blockade effect.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2008年第11期859-863,共5页 Journal of Clinical Cardiology
基金 国家自然科学基金项目(No:30470711)
关键词 替米沙坦 Kvl.5钾通道 卵母细胞 Ikur电流 Telmisartan Kv1. 5 potassium channels Xenopus Oocytes Ikur current
  • 相关文献

参考文献10

  • 1TIMMERMANS P B, WONG P C, CHIU A T, et al. Angiotensin II receptors and angiotensin II receptor antagonists[J]. Pharmacol Rev, 1993, 45:206 -- 251.
  • 2BURNIER M, BRUNNER H R. Angiotensin II receptor antagonists[J]. Lancet, 2000, 355: 637--645.
  • 3孙旭莉,尹兆波,赵静敏.ARB与高血压患者脑卒中预防[J].中国初级卫生保健,2005,19(4):87-88. 被引量:2
  • 4DELPON E, CABALLERO R, GOMEZ R, et al. Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization[J]. Trends Pharmacol Sci, 2005, 26:155--161.
  • 5CABALLERO R, DELPO'N E, VALENZUELA C, et al. Losartan and its metabolite E3174, modify cardiac delayed rectifier K^+ currents [J]. Circulation, 2000,101 : 1199-1205.
  • 6IGNACIO M, RICARDO C, GONZ'ALEZ T, et al. Effects of irbesartan on cloned potassium channels in volved in human cardiac repolarization[J]. J Pharmacol Exp Ther, 2003, 304; 862--873.
  • 7STANGIER J, ROTH W. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients[J]. J Int MedRes, 2000, 28 :149--167.
  • 8RICARDO C, EVA DELP'ON, CARMEN V, et al. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization[J]. Mol Pharmacol, 2000, 59 :825-- 836.
  • 9ZHANG H, ZHU B, YAOJ, TSENG G. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kvl. 4 : common site but different factors in determining blockersI binding affinity[J]. J Pharmacol Exp Ther, 1998, 287:332- 343.
  • 10NERBONNE J M. Molecular basis of functional voltage-gated K^+ channel diversity in the mammalian myocardium[J]. J Physiol, 2000, 525:285--298.

同被引文献10

  • 1TAMARGO J, CABALLERO R, GOMEZ R, et al. IKur/Kv1. 5 channel blockers for the treatment of at- rial fibrillation[J].Expert Opin Investig Drugs, 2009, 18:399-416.
  • 2DECHER N, KUMAR P, GONZAI.EZ T, et al. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kvl. 5 channels[J].Mol Pharmacol, 2005 ,68: 995-1005.
  • 3HOSHI T, ZAGOTTA W N, ALDRICH R W . Biophysical and molecular mechanisms of Shaker potassium channel inactivation[J]. Science , 1990 , 250 : 533 -538.
  • 4ZAGOTTA W N, HOSHI T, AI.DRICH R W. Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB[J]. Science, 1990 ,250:568-571.
  • 5LAGRUTTA A, FERMINI B, SALATA J. Novel potent inhibitors of cloned Kv1. 5 potassium channels and human IKur[J]. FASEB J , 2004, 18: 1054 - 1063.
  • 6ZHOU M, MORAIS-CABRAL J H, MANN S, et, al. Potassium channel receptor site for the inactivation gate and quaternary amine inhihitors[J]. Nature, 2001,411: 657-661.
  • 7ANTZ C, FAKLER B. Fast inactivation of voltagegated K+channels: from cartoon to structure[J]. News Physiol Sci,1998,13: 177-182.
  • 8ANTZ C, GEYER M, FAKLER B, et, al. NMR structure of inactiva-tion gates from mammalian voltage-dependent potassium channels[J].Nature, 1997, 385: 272-275.
  • 9KARCZEWSKI J, KISS L, STEFANIE A. High- throughput analysis of drug binding interactions for the human cardiac channel, Kvl. 5[J].Biochem Pharmacol, 2009,77: 177- 185.
  • 10AGONZ ' ALEZ T, AVARRO-POLANCO R. Assembly with the Kvβ1.3 Subunit modulates drug block of hKv1. 5 ehannels[J]. Mol Pharmacol, 2002,62: 1456-1463.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部